当前位置:首页 - 行情中心 - 盟科药业-U(688373) - 财务分析

盟科药业-U

(688373)

  

流通市值:39.88亿  总市值:49.76亿
流通股本:5.25亿   总股本:6.56亿

盟科药业-U(688373)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-1.94亿元,每股收益-0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益25755.41万元,未分配利润-199822.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产72693.42万元,负债46938.01万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入103,985,283.2466,969,753.0933,216,965.04130,272,762.01
营业总成本304,175,409.85209,906,680.3496,412,359.38581,598,318.57
其他经营收益
营业利润-192,915,786.08-138,071,955.4-61,631,420.62-434,488,730.84
利润总额-193,407,150.71-138,558,720.03-61,632,475.69-434,511,616.97
净利润-193,536,147.26-138,674,492.55-61,632,475.69-440,721,217.09
每股收益
其他综合收益-5,117,441.93-2,175,638.72-816,039.596,175,113.78
综合收益总额-198,653,589.19-140,850,131.27-62,448,515.28-434,546,103.31
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计640,046,361.72681,881,628.84757,668,471.24748,661,957.2
非流动资产:
非流动资产合计86,887,827.2291,021,128.6995,914,956.73100,466,702.42
资产总计726,934,188.94772,902,757.53853,583,427.97849,128,659.62
流动负债:
流动负债合计276,413,708.51255,577,971.57243,116,122.74212,296,583.22
非流动负债:
非流动负债合计192,966,402.11203,949,025.63226,146,768.6197,868,324.69
负债合计469,380,110.62459,526,997.2469,262,891.34410,164,907.91
所有者权益(或股东权益):
归属于母公司股东权益合计257,554,078.32313,375,760.33384,320,536.63438,963,751.71
股东权益合计257,554,078.32313,375,760.33384,320,536.63438,963,751.71
负债和股东权益合计726,934,188.94772,902,757.53853,583,427.97849,128,659.62
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计117,706,977.2574,196,489.7235,560,357.02140,148,380.61
经营活动现金流出小计283,335,004.11194,901,168.587,608,552.25587,329,115.94
经营活动产生的现金流量净额-165,628,026.86-120,704,678.78-52,048,195.23-447,180,735.33
投资活动产生的现金流量:
投资活动现金流入小计1,930,610,524.91,395,779,562.05856,791,336.863,007,544,042.27
投资活动现金流出小计1,753,725,494.861,358,240,751.28812,887,455.512,492,745,819.28
投资活动产生的现金流量净额176,885,030.0437,538,810.7743,903,881.35514,798,222.99
筹资活动产生的现金流量:
筹资活动现金流入小计91,702,238.6971,702,238.6964,479,490.67106,977,035
筹资活动现金流出小计37,650,658.5524,029,051.287,527,81838,882,257.26
筹资活动产生的现金流量净额54,051,580.1447,673,187.4156,951,672.6768,094,777.74
汇率变动对现金及现金等价物的影响-1,608,325.68-934,222.35-102,090.07143,372.07
现金及现金等价物净增加额63,700,257.64-36,426,902.9548,705,268.72135,855,637.47
期末现金及现金等价物余额337,032,548.26236,905,387.67322,037,559.34273,332,290.62
补充资料:
现金及现金等价物的净增加额--36,426,902.95-135,855,637.47
最新报告期:2025-09-23
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
光大证券叶思奥,王明瑞-0.37-0.23-0.122025-09-23
光大证券叶思奥,王明瑞-0.37-0.31-0.182025-08-27
TOP↑